|
|
||||||||
Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University, Tokyo 142-8555, Japan
Bufalin, an
Na+-K+-ATPase inhibitor, simultaneously
induced cell differentiation and apoptosis in human monocytic
leukemia THP-1 cells. In this study, we investigated the regulatory
role of protein kinase C (PKC) isozymes in bufalin-induced cell
differentiation and apoptosis. A PKC-specific but
isozyme-nonselective inhibitor, Ro-31-8220, and a cPKC selective
inhibitor, Gö-6976, caused significant attenuation of
bufalin-induced interleukin-1
(IL-1
) gene expression, a mature
monocytic marker, indicating that cPKC participates in the
bufalin-induced cell differentiation. On the other hand, cPKC
- and
nPKC
-defective THP-1/TPA cells displayed strong resistance to
the bufalin-induced DNA ladder formation. Rottlerin, an
nPKC
-specific inhibitor, partially attenuated preapoptotic effects
of bufalin, such as the limited proteolysis of nPKC
and
poly(ADP-ribose) polymerase and the cell staining by terminal
deoxynucleotidyl transferase-mediated dUTP nick end labeling,
suggesting that nPKC
is involved, at least in part, in
bufalin-induced apoptosis. In contrast, Gö-6976 and
rottlerin significantly augmented bufalin-induced apoptosis and
differentiation, respectively. The findings suggest that
bufalin-induced cell differentiation and apoptosis are
interlinked and that distinct PKC isozymes are involved in the fate of
the cell.
cell differentiation; apoptosis
This article has been cited by other articles:
![]() |
R. A. Newman, P. Yang, A. D. Pawlus, and K. I. Block Cardiac Glycosides as Novel Cancer Therapeutic Agents Mol. Interv., February 1, 2008; 8(1): 36 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Schoner and G. Scheiner-Bobis Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth Am J Physiol Cell Physiol, August 1, 2007; 293(2): C509 - C536. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Fedorova, M. I. Talan, N. I. Agalakova, M.-T. Droy-Lefaix, E. G. Lakatta, and A. Y. Bagrov Myocardial PKC {beta}2 and the Sensitivity of Na/K-ATPase to Marinobufagenin Are Reduced by Cicletanine in Dahl Hypertension Hypertension, March 1, 2003; 41(3): 505 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Dmitrieva and P. A. Doris Cardiotonic Steroids: Potential Endogenous Sodium Pump Ligands with Diverse Function Experimental Biology and Medicine, September 1, 2002; 227(8): 561 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gomez-Angelats and J. A. Cidlowski Invited Review: Cell Volume Control and Signal Transduction in Apoptosis Toxicol Pathol, August 1, 2002; 30(5): 541 - 551. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |